Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00831246 · ClinicalTrials.gov registry record · NA
Prevention of Ileus After Gynecologic Surgery Using Chewing Gum
A NA study of Ileus, sponsored by Aultman Health Foundation.
- Completed
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT00831246 is a NA study of Ileus that has completed, run by Aultman Health Foundation. The registered enrollment target is 400 participants, roughly in line with the 405-participant average among 5 other Ileus trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT00831246, a NA study of Ileus, has completed, sponsored by Aultman Health Foundation.
- COMPLETED
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will attempt to determine if the use of chewing gum can cause the early return of bowel function after gynecologic surgery.
Conditions Studied
Interventions
- OTHER chewing gum - Extra Winterfresh
- OTHER Standard Post-Op Care
Study Locations (1)
Ohio
- Aultman Health Foundation - Canton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2008-04 |
| Est. Completion | 2009-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00831246
The ClinicalTrials.gov registry entry for NCT00831246 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 405-participant average among 5 other Ileus trials with a reported enrollment target. The listed sponsor is Aultman Health Foundation, which has 12 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ileus appearing as the primary indexed condition, and to 2 interventions - of which chewing gum - Extra Winterfresh is the first listed.
NCT00831246 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT00831246 about?
NCT00831246 is a clinical study titled "Prevention of Ileus After Gynecologic Surgery Using Chewing Gum". This study will attempt to determine if the use of chewing gum can cause the early return of bowel function after gynecologic surgery.
What is the current status of trial NCT00831246?
This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2008-04. Estimated completion is 2009-04.
What conditions does trial NCT00831246 study?
This clinical trial studies the following conditions: Ileus.
What interventions are being tested in trial NCT00831246?
The interventions under investigation include: chewing gum - Extra Winterfresh (OTHER), Standard Post-Op Care (OTHER).
Who is sponsoring clinical trial NCT00831246?
This trial is sponsored by Aultman Health Foundation, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00831246 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ileus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Alvimopan and Ileus in PSF
COMPLETED · NA
-
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
COMPLETED · Phase 3
-
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
COMPLETED · Phase 3
-
A Study Evaluating Intravenous (IV) MOA-728 for the Treatment of Postoperative Ileus (POI) in Participants After Ventral Hernia Repair
COMPLETED · Phase 3
-
Study of Alvimopan for the Management of Opioid-induced Postoperative Bowel Dysfunction/Postoperative Ileus
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.